Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    TOPCAT
Show Display Options
Rank Status Study
1 Unknown  Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Conditions: Cardiovascular Diseases;   Heart Diseases;   Heart Failure, Congestive
Interventions: Drug: Spironolactone (an aldosterone antagonist);   Drug: Placebo
2 Completed Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Biological: monoclonal antibody HuHMFG1
3 Unknown  Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
Condition: Breast Cancer
Intervention: Biological: monoclonal antibody HuHMFG1

Indicates status has not been verified in more than two years